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Abstract In this review we start with a historical perspec-
tive beginning with the early morphological work done
almost 50 years ago. The importance of these pioneering
studies is underscored by our brief summary of the key
questions addressed by subsequent research into the mecha-
nism of secretion. We then highlight important advances in
our understanding of the formation and maturation of neu-
roendocrine secretory granules, Wrst using in vitro reconsti-
tution systems, then most recently biochemical approaches,
and Wnally genetic manipulations in vitro and in vivo.
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Morphological era of discovery (1950s and 1960s)
Visualization of the cell interior by electron microscopy
catalysed both morphologists and biochemists to initiate
experiments and make observations to identify, deWne and
understand the complex compartmentalization of specialized
cells, most notably including the morphologists G.E.
Palade, C. DeDuve, D.W. Fawcett, K.R. Porter, J. Rhodin
and F.S. Sjostrand. The exocrine pancreatic acinar was a
specialized cell type favoured by GE Palade, and it was
with this cell type that the Wrst observations on cells with
specialized granule compartments were made.
The complex morphology of the cell compartments,
and the desire to link a morphological observation with
basic biochemical functions and pathways known at that
time initiated the monumental eVort to couple a biochemi-
cal approach with EM observations. Indeed in 1956,
Palade observed intracisternal granules in the endoplas-
mic reticulum (ER) which resembled zymogen granules,
and postulated that the material in the intracisternal gran-
ules was possibly the same as the zymogen granules, and
these granules were related to the granules in the cells in
the endocrine pancreas, -cell granules (Palade 1956).
Using the pancreatic acinar cell model, experiments by
Siekevitz and Palade between the late 1950s and early
1960s deWned the role of the ER and other subcellular
compartments in the synthesis of zymogen granule pro-
teins, and resulted in a series of papers published in the
newly established Journal of Biophysical and Biochemi-
cal Cytology, soon to be renamed Journal of Cell Biology
(Siekevitz and Palade 1958, 1962). The concept that pro-
teins are transported from their site of synthesis, the ER,
through the Golgi complex was also being recognized and
visualized using EM autoradiography in the exocrine pan-
creas (Caro and Palade 1964), Wrst at a low temporal level
of resolution. Direct evidence for transport from ER
through Golgi to zymogen granules was then obtained
using more precise pulse-chase protocols on tissue slices
by Jamieson and Palade (Jamieson and Palade 1967a, b).
This technical advance was further exploited by Jamieson
who applied subcellular fractionation techniques to pulse-
labelled slices. Separation of the rough and smooth ER
from condensing vacuoles and zymogen granules allowed
a quantitative kinetic analysis and a direct demonstration
that proteins are transferred from the ER to zymogen
granules via condensing vacuoles (Jamieson and Palade
1967a, b).
This work was supported by Fondation pour la Reserche Medicale 
(FRM 20051105487) and Cancer Research UK.
J. Morvan · S. A. Tooze (&)
London Research Institute, Cancer Research UK, 
44 Lincoln’s Inn Fields, London WC2A 3PX, UK
e-mail: Sharon.tooze@cancer.org.uk244 Histochem Cell Biol (2008) 129:243–252
123
Parallel studies in the anterior pituitary gland showed that
discrete, small individual granules, called immature secretory
granules (ISG) in mammotroph cells originated from the
Golgi cisternae. These small ISGs coalesced into aggregates
surrounded by a single membrane, Wnally becoming mature
secretory granules (MSGs) (Smith and Farquhar 1966).
Additional information about the secretory process in mam-
motrophs was obtained using high resolution EM autoradi-
ography. ISGs (20–100 nm structures) were found to be
maximally labelled after 30 min pulse with [3H]-leucine, and
mature over the following 2 h to MSGs. This kinetic of matu-
ration correlated well with the observations in the exocrine
pancreas which demonstrated the condensing vacuoles were
labelled after 37 min (Jamieson and Palade 1967a). The com-
plexity of the secretory granule compartment was revealed in
subsequent studies on dispersed pituitary cells where four
types of secretory granules were detected (Salpeter and Farqu-
har 1981). After 15–55 min of chase the labelled protein was
found in small (Type I) ISGs, and subsequently in type II and
III polymorphic granules, and then larger Type IV MSGs
after 55–185 min of chase (see Fig. 1, and Farquhar et al.
1978). A higher degree of resolution was obtained using
newly developed Wne-grain emulsion which allowed an accu-
rate detection of small structures (20–100 nm), which com-
bined with a more sophisticated analysis of silver grain
distribution, led to the discovery that concentration of secre-
tory protein in the ISG compartment was 200 times that of the
adjacent Golgi cisternae (Salpeter and Farquhar 1981).
During this period TartakoV and colleagues outlined the
concept that secretory cells may have diVerent ways to
secrete newly synthesized proteins; cells such as plasma
cells, Wbroblasts, and macrophages secrete in a “non-regu-
lated” fashion in contrast to “regulated” cells such as exo-
crine pancreas, the hallmark of which is the storage of the
secretory proteins (TartakoV and Vassalli 1978). The nature
of the secretory pathways in such “non-storage” secretory
cells was also explored by the use of drugs that perturbed
secretion, such as monensin, a Na+/K+ ionophore which
causes a neutralization of acidic intracellular compartments,
or drugs that alter the energy status of the cell (TartakoV et al.
1977). The common requirement for energy, cyclic nucleo-
tides, Ca+, and cytoplasmic Na+/K+, in both non-regulated
and regulated cells, gave rise to the consensus that there is a
common secretory pathway originating in the RER, through
the Golgi complex (for review see Palade 1975).
Many of the observations made were obtained using
careful morphological approaches and expanded using bio-
chemical techniques, and subcellular fractionation. How-
ever, these early biochemical approaches were limited by
the inability to manipulate the cell systems in use, typically
tissues from mice or rats. The arrival of molecular tools and
genetic manipulation provided the next wave of advances
bringing the Weld to our current level of understanding.
Cell line model systems, the molecular age 
and the sorting problem
Regulated secretory cells, as well as other cell types such as
liver cells, have specialized plasma membrane domains,
which by deWnition have a unique composition. Therefore,
in addition to classiWcation of regulated versus non-regu-
lated secretion (also called constitutive secretion (Kelly
1985), it was recognized that there must be multiple ways
to reach distinct domains from the Golgi complex, in par-
ticular for membrane proteins. The Wrst direct demonstra-
tion of multiple routes to the plasma membrane was from
the work of Gumbiner and Kelly in 1982. Their observa-
tions using the AtT20 cell line, a mouse pituitary cell line,
showed that the regulated secretory hormone ACTH was
secreted with diVerent kinetics from a viral model mem-
brane protein, gp70, a glycoprotein of the endogenous
murine leukaemia virus. Surprisingly, the kinetics of the
secretion of a proportion of the ACTH precursor, POMC,
which escaped the activity of pro-hormone processing
Fig. 1 Mammotroph cell from the anterior pituitary gland of a lactat-
ing rat. This micrograph illustrates the morphological complexity of
the regulated secretory pathway, and the diVerent types of ISGs. ER
endoplasmic reticulum; CM cell membrane; SG secretory granule; SV
smooth vesicles; VE vesicle; LB lytic body. Reproduced from the J Cell
Biol, 1966, 31:319–347. Copyright 1966 The Rockefeller University
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enzymes present in the MSG was the same as gp70 (Gum-
biner and Kelly 1982). These experiments solidiWed “the
two pathways hypothesis” (Kelly 1985) which deWned dis-
tinct post-Golgi pathways for proteins targeted for regu-
lated and constitutive secretion. At this time it was also
recognized that the mechanism for segregation of cargo
proteins (either soluble or membrane associated), or sorting
into a particular pathway was an important issue, as was the
identiWcation of the precise location for the initiation of the
sorting process. A key technological advance in elucidating
both sorting and location was the development of immuno-
electron microscopy using thin, frozen sections (Tokuyasu
1980) which allowed the identiWcation of proteins within
subcellular compartments.
TGN and post-TGN sorting and processing 
in neuroendocrine cells
It was recognized in mid-1980s that the trans-Golgi network
(TGN) might be the key exit point for proteins destined to
the plasma membrane, constitutive secretory vesicles
(CSV), endosomes, and ISGs (GriYths and Simons 1986). It
was proposed that sorting receptors might function in this
compartment to segregate diVerent cargos into diVerent ves-
icles (Burgess and Kelly 1987). It also became apparent
from studies on the mannose-6-phosphate receptor (M6PR),
which with its bound lysosomal enzyme is sorted to endo-
somes, that sorting to endosomes from the TGN utilized
clathrin and clathrin-coated vesicles (Geuze et al. 1985). At
this time it was also proposed that CSVs were formed with-
out the aid of clathrin coats (GriYths et al. 1985). However,
clathrin-coated regions were detected on the surface of
-cell secretory granules associated with the TGN after
monensin treatment (Orci et al. 1984) or on ACTH-contain-
ing ISGs in AtT20 cells (Tooze and Tooze 1986) raising the
possibility that 1) ISGs formation is through clathrin-coated
regions of the TGN, or 2) that the biogenesis of ISGs
involved a clathrin-coated vesicle dependent pathway.
AcidiWcation of the TGN and post-TGN secretory com-
partments was increasingly recognized to be important for
both transport (see TartakoV et al. 1977) and sorting. A key
contribution at this time was the direct demonstration,
using DAMP labelling (Anderson et al. 1984), that the
TGN and post-TGN compartments were acidic, and there
was a gradient of acidiWcation in the secretory pathway. It
was proposed that acidiWcation could play role in receptor-
ligand uncoupling and recycling, thereby providing direc-
tionality to transport (Anderson and Pathak 1985).
Although the concentration of DAMP, was thought to be
proportional to the extent of acidiWcation, later studies pro-
vided accurate measures of pH of the TGN and ISG (see
review Moore et al. 2002).
Neutralization of acidic compartments caused mis-sort-
ing of regulated secretory proteins to the constitutive path-
way (Moore et al. 1983), a result which gave rise to the
possibility that regulated secretory proteins may have sort-
ing signals, and could be sorted by a receptor-ligand inter-
action in the TGN, or in a post-TGN compartment. The
most controversial observation in support of this hypothesis
was the proposed role for carboxypeptidase E as the sorting
receptor (Cool et al. 1997), although this was immediately
refuted (Irminger et al. 1997). Evidence in support for a
sorting signal was the demonstration that regulated secre-
tory proteins have transferable sorting signals, the Wrst
being in 1986 (Moore and Kelly 1986). An alternative
hypothesis was that aggregation of regulated secretory pro-
teins, best demonstrated for the Granins but also shown for
a variety of other regulated secretory proteins, and favoured
by low pH on the TGN, drives lumenal segregation of regu-
lated secretory proteins. The segregation of the regulated
secretory proteins maybe further enhanced by a homophilic
interaction with membrane associated population of Gra-
nins (Gerdes et al. 1989). Furthermore, evidence for forma-
tion of multiple secretory granule populations with diVerent
hormone content supports the idea that aggregation drives
sorting (Hashimoto et al. 1987). Some of these results form
the basis for the “sorting for entry” hypothesis, which pro-
poses that regulated secretory proteins are sorted into ISGs
in the TGN, while constitutively secreted proteins enter
CSVs (see review Tooze 1998).
Another model to explain sorting in the regulated path-
way was developed from experiments in -cells, where it
was shown that insulin-containing secretory granule forma-
tion is driven by the hexamerization and condensation of
insulin in the ISGs (Arvan et al. 1991). These studies
revealed an essential diVerence between neuroendocrine
cells and -cell insulin granules, giving rise to the “sorting
by retention” hypothesis (see review Arvan and Castle
1998) which proposes that rather than an active sorting in
the TGN, the crucial sorting step occurs in the post-TGN
ISGs. Both the “sorting for entry” and “sorting by reten-
tion” hypothesis agree on that non-regulated (possibly mis-
sorted) secretory proteins are removed by ISG-speciWc
clathrin-coated vesicles in a pathway called “constitutive-
like secretion”, after secretory granules have formed from
the TGN.
Most, if not all of the soluble regulated secretory pro-
teins are processed by the endopeptidases, the pro-hormone
convertases (PCs). Their discovery and Wnal molecular
characterization was driven by the original pioneering work
of Steiner and colleagues working in the -cell (Steiner
et al. 1974), and reviewed by (Seidah et al. 1993). These
enzymes are present in ISGs and MSGs, and are subjected
to the same sorting machinery as are proteins such as the
Granins. As their activity is pH-dependent, a large number246 Histochem Cell Biol (2008) 129:243–252
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of studies used the kinetics of their activation as monitors
for studying where and when the sorting of regulated pro-
teins occurred (see also below). A direct demonstration that
the site of prohomone processing of proinsulin was the
clathrin-coated ISG was obtained by immunocytochemistry
(Orci et al. 1985b), which were subsequently shown to be
acidic (Orci et al. 1986).
The progress from the 1950s until the early 1990s was
the result of many researchers’ eVort, most of which have
not been covered in this brief review. The reader is directed
to comprehensive reviews from the period (Burgess and
Kelly 1987; Mains et al. 1987), and more recently (Borgo-
novo et al. 2006; Dannies 2001; Kim et al. 2006; Meldolesi
et al. 2004; Solimena and Gerdes 2003). The main ques-
tions which we focus on in the next section are the molecu-
lar machinery of secretory granule formation and
maturation, as addressed by the work started in the labora-
tory of W. Huttner and continued in the author’s laboratory
which is largely based on in vitro reconstitution assays
using isolated TGN, and post-TGN subcellular compart-
ments, in particular ISGs as Wrst developed using Golgi
membranes by Rothman and colleagues (Fries and Roth-
man 1980).
In vitro reconstitution and biochemical analysis 
of secretory granule biogenesis
Cell-free reconstitution of ISG budding from TGN
While MSGs from a variety of tissues had been extensively
characterized morphologically as well as biochemically, lit-
tle was known about ISGs beyond their morphological
appearance (Smith and Farquhar 1966). The cell-free
reconstitution of secretory granule budding from the TGN
brought new insights to understanding the formation of
ISGs (Tooze and Huttner 1990). This assay was based on
(1) the high Wdelity sorting properties of PC12 cells which,
unlike AtT20 cells, target greater than 90% of their regu-
lated secretory protein to ISGs and MSGs, (2) the selective
labelling of a regulated secretory marker, secretogranin II
(SgII), and a constitutively secreted protein, heparan sulfate
proteoglycan (hsPG) with radioative sulfate by sul-
fotransferases present only in the TGN, and (3) the ability
to separate the TGN, ISGs and CSVs from one another by
sequential velocity and equilibrium gradients centrifuga-
tions. This assay demonstrated that SgII and hsPG were
present in two vesicle populations, SgII-containing regu-
lated secretory vesicles (ISGs), and hsPG-containing CSVs.
These results provided the Wrst demonstration that regu-
lated secretory proteins and constitutive secretory proteins
were sorted into two distinct vesicle populations directly
upon exit from the TGN, in support of the “sorting for
entry” hypothesis. The formation of both ISGs and CSVs
required GTP-binding proteins (Tooze et al. 1990), possi-
bly heterotrimeric G-proteins (Leyte et al. 1992). The rate
of formation of the ISGs was indistinguishable from the
CSVs, occurring with a t1/2 of 15 min.
In addition, the subcellular fractionation protocol
developed to distinguish ISGs and MSGs allowed the bio-
chemical and morphological characterization of ISGs, in
comparison to MSGs, isolated from PC12 cells (Tooze
et al. 1991). ISGs were shown to have several components
of the clathrin-coat machinery, including AP-1 (Dittié et al.
1996), and ARF1 (Austin et al. 2000), in addition to non-
granule proteins such as the M6PR and furin (Dittié et al.
1997, 1999). In addition, it was possible to determine the
size of ISGs and MSGs, results which provided direct sup-
port for the early EM autoradiography (Smith and Farquhar
1966) and became the basis for the experiments directed
towards a molecular understanding of the change in size of
the ISG through homotypic fusion and subsequent remodel-
ling of the ISG through clathrin coats (see Fig. 2).
Determination of the pH of ISGs using an in vitro approach
While it was known from earlier studies that in endocrine
cells MSGs are acidiWed it was not known what the precise
pH of the ISG was, and if the pH of the ISG diVered from
Fig. 2 Key steps in secretory granule biogenesis. Model based on data
discussed above, in addition to contributions from many researchers
which have not been mentioned, but whose contributions are noted.
Step 1 depicts the formation of ISGs from the TGN, Step 2 the homo-
typic fusion event between ISGs, and Step 3 the clathrin-mediated
membrane remodelling event. See text for abbreviationsHistochem Cell Biol (2008) 129:243–252 247
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the TGN. The establishment of a PC12 stable cell line
expressing the PC2 allowed us to characterize the endopep-
tidase PC2 activity during granule maturation (Dittié and
Tooze 1995). In this cell line, PC2 is correctly targeted to
the ISGs and co-sedimented with SgII in fractions contain-
ing ISGs and MSGs. [35S] sulfate labelling demonstrated
that SgII was proteolytically processed by PC2 in ISGs
after approximately 30 min of chase into several lower-
molecular-mass proteins, the major ones being a 18 and
28 kDa sulphated fragment.
As the eYciency of processing of SgII by PC2 was pH
dependent, we used the ability to quantitate the extent of
processing at diVerent pHs to determine the pH in the ISGs
(Urbé et al. 1997). Isolated ISGs and TGN, containing [35S]
sulfate pulse-labelled SgII were incubated in presence of
ATP at physiological pH and the extent of SgII processing
in these compartments was compared to a standard curve
prepared using ISGs equilibrated at a deWned set of pHs.
This allowed us to determine that the ISGs intra-granular
pH was 6.3, similar to the TGN pH and clearly higher than
the pH of MSGs (pH 5.5–5.0). Interestingly, no processing
of SgII could be observed in the membrane fraction highly
enriched in TGN under conditions for which processing
was readily obtained in isolated ISGs. This data represent
further evidence that the ISG is indeed a functionally dis-
tinct organelle from the TGN. Furthermore, the rate of SgII
processing was strongly dependent on the intragranular pH,
demonstrating that processing of SgII can be used as a pH
indicator for granule interior.
ISG-ISG homotypic fusion
As shown originally by Farquhar (Smith and Farquhar
1966) in the anterior pituitary, and more recently in PC12
cells (Tooze et al. 1991), ISGs increase in size during matu-
ration, and the increase in size was proposed to reXect
homotypic fusion of ISG. To demonstrate that ISG–ISG
fusion occurred, we developed an assay that provided the
Wrst biochemical evidence for such a fusion event and
allowed us to dissect the molecular requirements of this
process.
The cell-free assay to reconstitute homotypic fusion was
performed by mixing two populations of ISGs, one contain-
ing the pro-hormone convertase PC2 and the other contain-
ing [35S]sulfate-labelled secretogranin II (SgII) (Urbé et al.
1998). The fusion was then measured by quantiWcation of
the 18 kDa PC2 cleavage product of SgII. This in vitro
reconstitution of ISG-ISG fusion revealed that homotypic
fusion is dependent on NSF (Urbé et al. 1998), -SNAP
and on the SNARE Syntaxin 6 but not on Syntaxin 1 or
SNAP-25 (Wendler et al. 2001). More recently, Synapto-
tagmin IV (Syt IV), a member of the Synaptotagmin family
of proteins involved in membrane fusion, has also been
shown to be required for this step of granule maturation
(Ahras et al. 2006).
ISG membrane remodelling
In addition to ISG-ISG homotypic fusion, ISG content and
membrane remodelling is another important step during
granule maturation. This remodelling is performed via bud-
ding of clathrin-coated vesicle from the maturing granule
membrane, and is the pathway for non-regulated constitu-
tive-like secretion, or possibly sorting to endosomes. This
clathrin-mediated remodelling step is a common feature in
neuroendocrine and endocrine secretory granules, and is
thought to provide a mechanism for proof-reading the con-
tent and membrane composition of the maturing ISG to
ensure the production of MSGs which contain biologically
active hormones and can undergo eYcient exocytosis.
ISGs in endocrine and neuroendocrine cells were shown
by morphological techniques to be partially clathrin coated
(Orci et al. 1985a; Tooze and Tooze 1986) but the recruit-
ment mechanism and the composition of this clathrin coat
were unknown until a biochemical approach was used. Our
laboratory developed a fourth cell-free assay whereby the
recruitment of the clathrin adaptor complex AP-1 to ISGs
was reconstituted by the addition of bovine brain cytosol
(Dittié et al. 1996). These experiments showed that AP-1
recruitment to ISGs was ATP-independent but GTP- and,
ARF1-dependent. This study demonstrated that it is the
AP-1 complex that is involved in the clathrin binding to
ISGs. Cross-linking experiments demonstrated the direct
interaction of AP-1 and ARF1 on the ISG (Austin et al.
2000). The M6PR and furin are likely part of the cargo tar-
geted for removal from the ISGs by clathrin-coats as they
possess sequences in their cytoplasmic domains which
interact with AP-1, and are present on ISGs, but absent
from MSGs (Dittié et al. 1997, 1999).
Further investigation into cargo sorting from the ISG
showed that VAMP4, a SNARE involved in endosome to
TGN vesicle traYcking, which is present on ISGs but
removed from the maturing granule membrane, is also able
to bind AP-1. The recruitment of AP-1 by VAMP4 is
dependent on phosphorylation of the cytoplasmic domain
of VAMP4 by the kinase CKII. CKII phosphorylation of
VAMP4 allows the recruitment of PACS1 to ISGs enhanc-
ing the AP-1 dependent sorting event (Hinners et al. 2003).
These data suggest that sorting non-regulated secretory pro-
teins from ISGs, including the SNARE proteins, can be
mediated by the recruitment of clathrin coats and may be
essential for maturation of ISGs.
More recently, our laboratory demonstrated that the
GGAs proteins are also involved in this clathrin-mediated
membrane-remodelling step of secretory granule matura-
tion. GGAs (Golgi-associated, -ear-containing, ADP-ribo-248 Histochem Cell Biol (2008) 129:243–252
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sylation factor-binding protein) are involved in recruitment
of AP-1 and clathrin coats to membranes (for review see
Robinson and Bonifacino 2001). siRNA mediated knock-
down of GGA3 and over-expression of dominant negative
form of GGA proteins resulted in a retention of the
SNAREs Syntaxin 6 and VAMP4 in the MSGs. In addition,
an alteration of the PC2 activity was also detected, suggest-
ing that inhibition or alteration of clathrin-coat remodelling
inhibited or altered intra-lumenal acidiWcation (Kakhlon
et al. 2006). Similar eVects on PC2 activity were seen after
siRNA mediated knock-down of Syt IV, suggesting that
inhibition of either homotypic fusion or remodelling have
similar detrimental eVects on acidiWcation of ISGs.
It was proposed that secretory granules, like other mem-
branes have lipid micro-domains, or rafts (Tooze et al.
2001), and that the lipid composition of the secretory gran-
ule membrane is important for protein sorting during clath-
rin-coat mediated membrane remodelling. In fact,
cholesterol was shown to be an important component in
secretory granule formation (Wang et al. 2000). Recent
work by Katsumata et al. (2007) has shown that the secre-
tory granule membrane is composed of two kinds of micro-
domains and that the proteins expected to be removed dur-
ing the membrane remodelling (VAMP4 and Syntaxin6)
are clustered together in the same micro-domain and sepa-
rated from the proteins (VAMP2) that stay on the MSG
membrane. These experiments validate our observations
(see above), as well as the work by H.P. Moore in AtT20
cells (Eaton et al. 2000) and provide new information that
opens new avenues for research into the role of lipids in
sorting from ISGs.
Recent developments in secretory granule formation 
and maturation
In this last section we summarize the most recent develop-
ments in our understanding of secretory granule biogenesis
obtained from biochemical screens, in vivo experiments
based on genetic manipulation of cell in culture as well as
in vivo transgenic mouse models. Only a small number of
recent results are highlighted and readers are directed to
recent reviews (Borgonovo et al. 2006; Dannies 2001; Kim
et al.  2006; Meldolesi et al. 2004; Solimena and Gerdes
2003). The experiments we highlight show the direction
that the Weld has taken, and the way less tractable questions
can be addressed by new biochemical screens and trans-
genetic mouse models.
Role of cholesterol in secretory granule biogenesis
Secretory granule formation is dependent on lipid raft
microdomains that are enriched in cholesterols (Wang et al.
2000). A recent investigation of the role in vivo of choles-
terol in secretory granule biogenesis was done using
Smith–Lemli–Opitz Syndrome (SLOS) and lathosterolis
mouse models (Gondre-Lewis et al. 2006). Both diseases
are a result of inborn errors in cholesterol synthesis. SLOS
is a disease caused by a defect in the function of the
enzyme, 7-dehydrocholesterol reductase (DHCR7),
required for the Wnal step of cholesterol biosynthesis.
Patients with lathosterolosis lack lathosterol-5-desaturase
(SC5D), the enzyme that catalyse the next-to-last step in
cholesterol synthesis. Data obtained from DHCR7 and
SC5D knock-out mice demonstrated that impairment of the
cholesterol biosynthesis results in a signiWcant decrease in
secretory granules in pancreas, pituitary and adrenal glands.
In addition, abberant zymogen granules were found in the
exocrine pancreas, in which there was also observed a
decrease in regulated secretion which could be rescued with
exogenous cholesterol. The authors conclude that the pres-
ence of an elevated quantity of other sterols, 7-DHC and
lathosterol, in Dhcr7-/- and Sc5d-/- mice, respectively,
could not replace cholesterol in the regulated secretory
pathway. They speculate that the abnormal properties of the
secretory granule in these mice models may be attributed to
the reduced rigidity of membranes containing these sterols
instead of cholesterol. Importantly, this study demonstrates
that cholesterol is essential during secretory granule bio-
genesis in vivo.
Regulation of secretory granule maturation
Peptidylglycine -amidating monooxygenase (PAM) is an
essential enzyme in the processing of many bioactive pep-
tides and hormones (Prigge et al. 2000). PAM is targeted to
the regulated secretory pathway in neurons and neuroendo-
crine cells. It is a type I membrane protein containing two
enzymatic domains within the lumen of the secretory gran-
ule, a transmembrane domain, and a cytosolic domain con-
taining sorting signals. PAM catalyses one of the Wnal steps
in peptide biosynthesis, and is retrieved from ISGs and the
plasma membrane for re-utilization in newly forming secre-
tory granules (Ferraro et al. 2005). Among the proteins able
to interact with PAM are two Rho guanine nucleotide
exchange factors (GEFs), Kalirin and Trio, identiWed by
yeast two-hybrid screens using the cytosolic domain of
PAM as bait (Alam et al. 1996; Xin et al. 2004).
In a recent study, Kalirin and Trio have been shown to
be involved in the maturation of secretory granules (Ferraro
et al.  2007). Overexpression of their N-terminal GEF
domain enhances secretion from ISGs, reducing regulated
secretory protein storage through constitutive-like secre-
tion, in the absence of secretagogue stimulation of regu-
lated exocytosis. Conversely, when GEF activity is
inhibited the constitutive-like release is inhibited, resultingHistochem Cell Biol (2008) 129:243–252 249
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in the accumulation of cargo in MSGs above even normal
levels. These results indicate that these two Rho-GEFs reg-
ulate sorting into secretory granules, constitutive-like secre-
tion from ISGs, and perhaps constitutive secretion, and
provide a novel mechanism for the regulation of secretory
granule maturation.
Role of Chromogranin A in secretory granule formation
Chromogranin A (CgA) and B (CgB), members of the Gra-
nin family, have long been proposed to control the secre-
tory granule biogenesis because of their pH-, calcium- and
catecholamine-dependent aggregation properties, and wide-
spread expression pattern. Recent results supports this
hypothesis, however other recent results suggest that the
regulated phenotype (Day and Gorr 2003; Meldolesi et al.
2004) is not simply conferred by expression of CgA.
In support of the hypothesis, in 2001, Kim et al. demon-
strated that speciWc depletion of CgA, but not of CgB, by
siRNA impaired secretory granule production in PC12
cells. In contrast, over-expression of CgA in 6T3 cells lack-
ing CgA and the regulated secretory pathway, or Wbroblas-
tic CV-1 cells, not only triggered recovery of secretory
granules but also regulated secretion (Kim et al. 2001).
However, Malosio et al.(2004) refuted the hypothesis by
demonstrating with very similar approaches that the “newly
formed” vesicles which contained the CgA were in fact
lysosomes, and overexpression of CgA did not induce the
appearance of secretory granules, or alter the number of
secretory granules.
Three groups used mouse models to determine the role
of Chromogranin A in vivo by targeted ablation of the
Chromogranin A gene. Mahapatra et al.(2005) conWrmed
the putative role of CgA in secretory granule biogenesis, in
particular a decrease of chromaYn granule size and num-
ber. In addition, defects were observed in neurotransmitter
storage and release and regulation of blood pressure. Simi-
lar results were obtained using anti-sense vectors speciWc
for CgA in transgenic animals which resulted in a reduction
of the CgA levels (Kim et al. 2005). In the adrenal medulla
of these mice there was a large decrease in the number of
secretory granules; in addition it was noted that the secre-
tory granules present appeared to be swollen. This defect
may be related to a need to maintain a proportional cate-
cholamine and CgA concentrations.
Lastly, Hendy et al. (2006) found that the CgA null
mutant mice had elevated secretion of epinephrine, norepi-
nephrine and dopamine and that mRNA and protein level of
other secretory granule proteins were up-regulated. No obvi-
ous abnormalities in development or neuronal and endocrine
functions have been noticed. The authors suggested then
that the increased expression of the other Granin family
members is likely to compensate for the CgA deWciency.
Role of prohormone convertases in secretory 
granule maturation
Both in vitro and ex vivo the activity of the PC enzymes
(notably PC1/3 and PC2 which will be the focus of the dis-
cussion here) have been extensively studied. PC null mice
models have conWrmed the in vivo function of the PCs and
extended the characterization of their speciWc substrates
and action in diVerent tissues.
The  Wrst PC transgenic mice model obtained was the
PC2 null mouse (Furuta et al. 1997). Mice lacking PC2
activity develop normally and are fertile, but exhibit a vari-
ety of neuroendocrine processing abnormalities in the brain
and in pancreatic islets. These mice show elevated levels of
pro-insulin (Furuta et al. 1998) and pancreatic islet pro-glu-
cagon processing is completely blocked. Other defects in
PC2 null animals include lack of production of -MSH
associated with accumulation of ACTH in the pituitary
intermediate lobe (Laurent et al. 2002).
7B2, also known as SgV or SGNE-1, is a small acidic
protein exclusively localized to neuroendocrine tissues.
This protein has been shown to be associated to PC2 and it
functions as a chaperone for PC2 (Braks and Martens
1994), and for review see Mbikay et al. (2001). A 7B2 null
transgenic mice model has shown that 7B2 is required for
PC2 activation in vivo, having in addition important func-
tions in regulating pituitary hormone secretion (Westphal
et al.  1999). 7B2 null mice have no demonstrable PC2
activity, and in general agreement with the PC2 null mouse
(Furuta et al. 1997), are deWcient in processing islet hor-
mones and display hypoglycemia, hyperinsulinemia, and
hypoglucanemia, with generalized islet cell expansion and
altered islet cell morphology. However, the most important
impairment of PC2-mediated peptide processing in 7B2
nulls involved the synthesis of the corticotrophin ACTH.
ACTH is produced by cleavage of POMC through the
action of PC1/PC3, further internal cleavage of ACTH
occurs by the action of PC2 speciWcally in the neurointer-
mediate lobe. In 7B2 nulls, ACTH remains intact in the
intermediate lobe, resulting in extremely high levels of
ACTH in this lobe (Westphal et al. 1999). The overall phe-
notype suggests that 7B2 may be involved in PC2 activity,
as well as secretory granule biogenesis.
Finally, the role of the PC1/3 endopeptidase has also
been investigated in a transgenic mouse model. Disruption
of gene-encoding mouse PC1/PC3 results in a syndrome of
severe post-natal growth impairment and multiple defects
in processing many hormone precursors, including hypo-
thalamic growth hormone-releasing hormone (GHRH),
pituitary proopiomelanocortin to adrenocorticotropic hor-
mone, islet proinsulin to insulin and intestinal proglucagon
to glucagon-like peptide-1 and -2 (Zhu et al. 2002). In sum-
mary, the analysis of PC2, 7B2 and PC1/3 null mice has250 Histochem Cell Biol (2008) 129:243–252
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conWrmed that PCs play a crucial role in the processing of
many hormone precursors and the highlight the importance
of PC2 and PC1/3 in neuroendocrine tissues, and regulated
secretion.
Role of Rab3D in secretory granule maturation
Rab proteins are small GTPases that belong to the Ras pro-
tein superfamily and that function in membrane traYc.
Rab3A is one of the best-characterized Rab protein. In
mammals, three additional isoforms are expressed which
are referred to as Rab3B, Rab3C and Rab3D. Rab3A,
Rab3B and Rab3C are predominantly expressed in the ner-
vous system, where they are localized to synaptic vesicles
(Fischer von Mollard et al. 1994; Martelli et al. 2000).
Rab3A-deWcient mice studies suggested that Rab3A has a
function intimately associated with fusion more than a
function in vesicle tethering at the synapse (Geppert et al.
1997).
In contrast to Rab3A, Rab3B and Rab3C, Rab3D is pre-
dominantly expressed outside the nervous system, in
peripheral tissues where the other isoforms either are
expressed at low levels or are lacking. Originally identiWed
in fat cells, Rab3D is present in several additional cell types
including secretory cells such as pancreatic and parotid aci-
nar cells, mast cells and peptide-secreting cell lines. In
secretory cells Rab3D appears to be predominantly local-
ized to secretory granules, thus mirroring the distribution of
Rab3A in neurons and neuroendocrine cells. It was hypoth-
esised that Rab3D could have the same function as Rab3A
but in secretory cells.
Riedel et al. (2002) investigated the role of this Rab3
isoform by knocking out the Rab3D gene in mice. Rab3D-
deWcient mice are viable and fertile and showed no obvious
defect. In particular, both kinetics and dose response of
secretagogue-induced enzyme secretion of the pancreas
were normal. However, these mice show a substantially
increased size of secretory granules in both exocrine pan-
creas and the parotid gland with the volume being doubled,
while the intragranular protein concentration appears to be
unchanged. These data suggest that Rab3D functions in
granule maturation but not in exocytic membrane fusion.
Conclusions and future perspectives
The early morphological and biochemical characterization
of the regulated secretory pathway provided key insights to
the secretory process. More recent experiments have pro-
vided a more detailed understanding of the functional prop-
erties, and the regulation of the maturation of
neuroendocrine secretory granules. Many important issues
need to be resolved, for example how the cytoplasmic
events, such as membrane remodelling are coupled with the
intralumenal biochemical changes such as PC activation,
prohormone cleavage, and acidiWcation. In addition, the
biological relevance of the maturation process, as it aVects
hormone processing and secretion, remains to be deter-
mined in light of the diVerences between endocrine and
neuroendocrine granules.
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